SCHEMBL725065

SCHEMBL725065

CNC(=O)c1csc(-c2ccccc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.53
HPGD P15428 3/20 0.53
ALDH1A1 P00352 3/20 0.53
NPC1 O15118 2/20 0.53
KDM4E B2RXH2 2/20 0.53
HTR3E A5X5Y0 1/20 0.52
HTR3B O95264 1/20 0.52
CHRNA7 P36544 1/20 0.52
HTR3A P46098 1/20 0.52
HTR3D Q70Z44 1/20 0.52
HTR3C Q8WXA8 1/20 0.52
MAPT P10636 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
IKBKB O14920 1/20 0.48
DHPS P49366 1/20 0.47
CHEK1 O14757 2/20 0.47
MAP4K4 O95819 1/20 0.47
BAZ2B Q9UIF8 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27502602 0.83 KDM4E (0.53) RAB9AALDH1A1KDM4EHTR3EHTR3B
SCHEMBL10367391 0.81 MAPT (0.52) RAB9AHPGDALDH1A1NPC1KDM4E
SCHEMBL27605120 0.80 HSD17B1 (0.52) HPGDALDH1A1HTR3EHTR3BCHRNA7
SCHEMBL938500 0.80 KMO (0.52) RAB9AHPGDALDH1A1NPC1KDM4E
SCHEMBL2454052 0.80 TSHR (0.53) RAB9AHPGDALDH1A1KDM4EHTR3E
SCHEMBL10367856 0.77 ATM (0.55) RAB9AHPGDALDH1A1NPC1HTR3E
SCHEMBL6666581 0.77 IKBKB (0.53) HPGDALDH1A1HTR3EHTR3BCHRNA7
SCHEMBL11394556 0.76 CA2 (0.50) HPGDALDH1A1HTR3EHTR3BCHRNA7
SCHEMBL723332 0.75 HDAC8 (0.70) MAPTBAZ2BHDAC8HDAC6
SCHEMBL28875555 0.74 RAB9A (0.55) RAB9ANPC1MAPTSMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012027481-A9 COMPOUNDS FOR TREATMENT OF CANCER GTX, INC. (US) 2013-10-10 WO disclosed
EP-2608671-A1 COMPOUNDS FOR TREATMENT OF CANCER Gtx, Inc. (US) 2013-07-03 EP disclosed
WO-2012027481-A1 COMPOUNDS FOR TREATMENT OF CANCER GTX, INC. (US) 2012-03-01 WO disclosed